Riskpilot← Back to searchSign inGet full accessOptiCell Solutions AB
ABActiveOrg 5594736125Hälsovägen 7 Våning 5 Postbox 1Medical specialists activities · NACE 8622Est. 20241-4 employees
Revenue 2024
SEK -62K
EBITDA margin
2110.9%
Equity ratio
74.6%
Financial strength
Net profit 2024
SEK -1,3M
| Revenue | SEK -62K | — |
| EBITDA | SEK -1,3M | — |
| Net profit | SEK -1,3M | — |
| Total assets | SEK 984K | — |
| Equity | SEK 734K | — |
| Employees | — | — |
Legal name
OptiCell Solutions AB
Org number
5594736125
Legal form
Aktiebolag
NACE code
8622 · Medical specialists activities
Founded
26 februari 2024
Share capital
SEK 25 000
Employees
1-4
VAT registered
Yes
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen Firman tecknas två i förening av ledamöterna Dessutom har verkställande direktören rätt att teckna firman beträffande löpande förvaltningsåtgärder
Company purpose
Aktiebolaget ska direkt eller indirekt bedriva cellterapiutveckling och terapeutiska afereser genom att samla in målceller för sjukvården och för forskning samt att erbjuda aferestjänster till den regionala hälso- och sjukvården samt erbjuda tjänster för cellsamlingar, aferesbehandlingar, utbildningar samt konsultation samt idka annan därmed förenlig verksamhet.
Address
Hälsovägen 7 Våning 5 Postbox 1
Email
opticellsolutions@opticellsolutions.com
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2024 |
|---|---|
| Revenue | −62 |
| Staff expenses | −947 |
| EBITDA | −1 302 |
| Depreciation & amort. | — |
| EBIT | −1 302 |
| Net financials | 11 |
| Profit before tax | −1 291 |
| Tax | — |
| Net profit | −1 291 |
| Item | 2024 |
|---|---|
| Total assets | 984 |
| Equity | 734 |
| Long-term debt | 44 |
| Short-term debt | 206 |
| Total debt | 250 |
EBITDA margin
-130170200.0%
This company
15.8%
Market median
-823862125% vs market
20242024
Equity ratio
74.6%
This company
38.2%
Market median
+95% vs market
20242024
Return on equity
-175.7%
This company
18.4%
Market median
-1055% vs market
20242024
Net profit margin
-129062900.0%
This company
8.1%
Market median
-1593369236% vs market
20242024
Asset turnover
-0.06×
This company
1.12×
Market median
-105% vs market
20242024
Debt / equity
0.34×
This company
0.62×
Market median
+45% vs market
20242024
- Annual report 2024Filed via Bolagsverket / SCB · Period 2024-02-26 – 2024-12-31
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
CS | Audit | 2024 | — | — |
JK Chief Executive Officer | Chief Executive Officer | 2024 | — | — |
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
| Deputy Board Member | 2024 | — | — | |
| Board of Directors | 2024 | — | — | |
| Chairman | 2024 | — | — | |
| Board of Directors | 2024 | — | — |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of OptiCell Solutions AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Claes-Göran Sten Rapp | Audit | 0 companies |
| Jarmo Kalervo Henriksson | Chief Executive Officer | 0 companies |
| Leif Rune Staffan Sahlström | Deputy Board Member | 0 companies |
| Camilla Marianne Nordström | Board of Directors | 0 companies |
| Erik Peter Rybäck | Chairman | 0 companies |
| Kent Patrik Sund Åvestrand | Board of Directors | 0 companies |